We also analyzed IDO-protein expression in tumor cells (MDA-MB-231 and BT-474), since IDO is considered a major contributor to tumor-induced immune suppression and a negative regulator of the immune system modulating T cell proliferation and immune tolerance associated with regulatory FoxP3+ T-cells in breast cancer [52]. The gene discussed is FOXP3; the disease is breast carcinoma.